Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868941 | 12586894 | 1 | I | 20160718 | 20160725 | 20160725 | EXP | RO-ROCHE-1799344 | ROCHE | CAINAP C, NAGY V, SEICEAN A, GHERMAN A, LASZLO I, LISENCU C, NADIM A, CONSTANTIN A AND CAINAP S. RESULTS OF THIRD-GENERATION EPIRUBICIN/CISPLATIN/XELODA ADJUVANT CHEMOTHERAPY IN PATIENTS WITH RADICALLY RESECTED GASTRIC CANCER. JOURNAL OF BALKAN UNION OF ONCOLOGY 2016;21 (2):349-359. | 0.00 | Y | 0.00000 | 20160725 | OT | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868941 | 12586894 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | DAYS 1-14 | U | 20896 | 1000 | MG/M**2 | BID | ||||||
| 125868941 | 12586894 | 2 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | DAY 1 | U | 0 | 50 | MG/M**2 | QD | ||||||
| 125868941 | 12586894 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | DAY 1 | U | 0 | 60 | MG/M**2 | QD | ||||||
| 125868941 | 12586894 | 4 | SS | 5-FU | FLUOROURACIL | 1 | Unknown | DAYS 1-5 | U | 0 | QD | ||||||||
| 125868941 | 12586894 | 5 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | DAY 1-5 | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125868941 | 12586894 | 1 | Gastric cancer |
| 125868941 | 12586894 | 2 | Gastric cancer |
| 125868941 | 12586894 | 3 | Gastric cancer |
| 125868941 | 12586894 | 4 | Gastric cancer |
| 125868941 | 12586894 | 5 | Gastric cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125868941 | 12586894 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125868941 | 12586894 | Diarrhoea | |
| 125868941 | 12586894 | Haemoglobin abnormal | |
| 125868941 | 12586894 | Palmar-plantar erythrodysaesthesia syndrome | |
| 125868941 | 12586894 | Platelet count abnormal | |
| 125868941 | 12586894 | Vomiting | |
| 125868941 | 12586894 | White blood cell count abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |